The Chemotherapy Question Nobody Asked in Four Major Endometrial Cancer Trials
RUBY, NRG-GY018, AtTEnd, and DUO-E4 all proved immunotherapy works in dMMR endometrial cancer. None of them tested whether chemotherapy...
RUBY, NRG-GY018, AtTEnd, and DUO-E4 all proved immunotherapy works in dMMR endometrial cancer. None of them tested whether chemotherapy...
A new pilot shows early diversity planning cuts mid-trial amendments, here's what that means for site selection, IRT setup,...
MA beneficiaries received kidney transplants at nearly half the rate of traditional Medicare patients post-Cures Act, a disparity that...
FDA's September 2026 adcomm recruitment push signals shifts in protocol feedback loops that sponsor clinops and sites can't afford...
Phesi finds fewer than 1 in 3 trial protocols connect to real patient data — meaning flawed assumptions reach...
Phesi's 2026 analysis found fewer than 1 in 3 trial protocols are linked to patient data—meaning AI tools are...
A JAMA RCT on ICU restraint strategies just proved rigorous trial design works even in critically ill patients —...